Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study
- 1 February 1975
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 31 (2) , 143-156
- https://doi.org/10.1038/bjc.1975.19
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma.1974
- BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial.1973
- Immunotherapy for Acute Myelogenous LeukaemiaBritish Journal of Cancer, 1973
- Effect of Active Immunization with Irradiated Tumour Cells on Specific Serum Inhibitors of Cell-mediated Immunity in Patients with Disseminated CancerBritish Journal of Cancer, 1973
- Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapyJournal of Surgical Oncology, 1973
- Combined chemoimmunostimulation therapy against murine leukemia.1972
- Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesisCancer, 1971
- Autoimmunization with Irradiated Tumour Cells in Human Malignant MelanomaBMJ, 1970
- Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).1970
- AN IMMUNOLOGICAL METHOD OF INCREASING THE SENSITIVITY OF PRIMARY SARCOMAS TO LOCAL IRRADIATION WITH X RAYSThe Lancet, 1964